Physician

Effat Rasul, M.D.

According to 2025 Medicare claims, Effat Rasul, M.D. (NPI: 1699086561) practices internal medicine in the Lake Charles, LA market, with the plurality of this provider's patient population coming from Calcasieu, LA. This provider's primary affiliated billing organization is IMPERIAL HEALTH, LLP (NPI: 1053352401; TIN: 721005645) and primary practice location at 70605-7183. Rasul is affiliated with the Aledade 35 Lagniappe MSSP Enhanced (ACO ID: A3899) and Sound Physicians Long Term Care Management, LLC (ACO ID: A5220), participating under the MSSP model.

Rasul's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 311 traditional Medicare patients, billed 3,681 HCPCS/CPT codes, and received $146,227 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 6,697 prescription claims across 521 beneficiaries totaling $885,381 in drug costs, led by Mounjaro (Tirzepatide). DME data shows 13 claims. Open Payments data shows 39 records totaling $706. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $90,885 and ending at $146,227. Concurrently, Part D prescription costs have risen steadily, from $7,697 to $885,381. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $1,850 and ending at $7,423.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$73K$146K2015 Medicare payment: $90,885 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $110,841 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $113,683 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $95,517 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $132,797 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $108,354 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $91,234 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $50,425 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $87,684 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $146,227 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20154181,292$90,885
20163851,415$110,841
20173851,396$113,683
20183481,132$95,517
20194911,637$132,797
20202271,391$108,354
20212081,147$91,234
20221291,307$50,425
20231681,993$87,684
20243113,681$146,227

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$443K$885K2015 Drug cost: $7,697 (USD; Tot_Drug_Cst)2016 Drug cost: $17,520 (USD; Tot_Drug_Cst)2017 Drug cost: $18,910 (USD; Tot_Drug_Cst)2018 Drug cost: $12,490 (USD; Tot_Drug_Cst)2019 Drug cost: $18,224 (USD; Tot_Drug_Cst)2020 Drug cost: $17,660 (USD; Tot_Drug_Cst)2021 Drug cost: $7,551 (USD; Tot_Drug_Cst)2022 Drug cost: $63,354 (USD; Tot_Drug_Cst)2023 Drug cost: $483,832 (USD; Tot_Drug_Cst)2024 Drug cost: $885,381 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015101203$7,697
2016115281$17,520
2017129317$18,910
201884218$12,490
2019144335$18,224
202092306$17,660
202164171$7,551
2022139868$63,354
20232963,766$483,832
20245216,697$885,381

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$3.1K$6.2K2015 Medicare payment: $305 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $6,220 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $5,622 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $4,019 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $1,917 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $3,165 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $771 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $137 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $6,064 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/R32$305
201625116$6,220
201724168$5,622
2018N/R125$4,019
2019N/R63$1,917
2020N/R114$3,165
2021N/R59$771
2022N/R22$137
2023N/RN/RN/R
2024N/R13$6,064

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
G0439Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit148148$120
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more293794$86
80061Blood test, lipids (cholesterol and triglycerides)131144$13
80053Blood test, comprehensive group of blood chemicals143174$10
36415Insertion of needle into vein for collection of blood sample162234$9

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
MounjaroTirzepatide1795,923$218,878
OzempicSemaglutide994,140$130,196
FarxigaDapagliflozin Propanediol583,282$62,810
JanuviaSitagliptin Phosphate473,270$60,366
JardianceEmpagliflozin472,670$52,277

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
A4239Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of serviceNN/R13$6,064

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.39$706AstraZeneca Pharmaceuticals LP
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Effat Rasul, M.D.?

Tedicare shows public-source Medicare data for Effat Rasul, M.D. (NPI 1699086561), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Effat Rasul, M.D. have ACO affiliation data?

Effat Rasul, M.D. is shown with ACO affiliation data for Aledade 35 Lagniappe MSSP Enhanced (MSSP, ACO ID A3899) and Sound Physicians Long Term Care Management, LLC (MSSP, ACO ID A5220).

What billing organization is linked to Effat Rasul, M.D.?

Effat Rasul, M.D. is linked to IMPERIAL HEALTH, LLP (billing NPI 1053352401) in the available physician profile data.

Does Effat Rasul, M.D. have Open Payments data?

Effat Rasul, M.D. has 39 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.